Table 3.
Comparison of biochemical variables between CVID patients and control group
| Variables | CVID Patients (n = 32) |
Control group (n = 37) |
p* |
|---|---|---|---|
| Median (IQ25–75) | Median (IQ25–75) | ||
| GPX activity U/L | 7.682 (6548–8446) | 9.284 (8440–10,720) | 0.002 |
| Selenium μg/L | 45.6 (37.3–56.2) | 57.8 (46.0–66.0) | 0.004 |
| MDA nmol/mL | 3.5 (3.1–3.9) | 3.2 (2.4–4.0) | 0.514 |
| us-CRP mg/L | 6.3 (0.9–17.7) | 1.8 (0.8–1.8) | 0.124 |
| Glucose mg/dL | 85.5 (81.0–92.0) | 85.0 (77.0–95.0) | 0.813 |
| Insulin U/mL | 6.6 (2.6–10.8) | 8.1 (5.2–13.8) | 0.155 |
| HOMA-IR | 1.2 (0.5–2.2) | 1.6 (0.9–2.9) | 0.177 |
| AST U/L | 19.0 (15.5–24.0) | 18.0 (15.0–19.0) | 0.116 |
| ALT U/L | 10.0 (8.0–14.0) | 12.0 (9.0–17.0) | 0.108 |
| GGT U/L | 14.0 (10.3–25.8) | 16.3 (10.7–21.5) | 0.519 |
Significance level of Mann-Whitney test
GPX Erythrocyte glutathione peroxidase, us-CRP Ultrasensitive protein C reactive, MDA Malondialdehyde, HOMA-IR Homeostasis Model Assessment for Insulin Resistance, AST Aspartate transaminase, ALT Alanine aminotransferase, GGT Gamma-glutamyl transferase